Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NA

Amoxicillin 3H2O Impurete A

NA
NA

Amoxicillin 3H2O Impurete B

NA
NA

Amoxicillin 3H2O Impurete D+E

NA
NA

Amoxicillin 3H2O Impurete F

NA
NA

Amoxicillin 3H2O Impurete G

NA
5908-99-6

Atropine Sulfate

5908-99-6
83905-01-5

Azithromycine

83905-01-5
59-66-5

Acetazolamide

59-66-5
39831-55-5

Amikacine disulfate

39831-55-5
111470-99-6

Amlodipine Besylate

111470-99-6
51264-14-3

Amsacrine

51264-14-3
320-67-2

Azacitidine

320-67-2
10439-39-1

Anthraquinone D8

10439-39-1
137-88-2

Amprolium HCl

137-88-2
55589-62-3

Acesulfam potassium

55589-62-3
578-66-5

8-Aminoquinoline

578-66-5
580-17-6

3-Aminoquinoline

580-17-6
139272-66-5

Aceclofenac Methyl Ester

139272-66-5
438-22-2

Androstan-5-alpha

438-22-2
89-65-6

Isoascorbic acid

89-65-6